Denali Therapeutics (DNLI) Tax Provisions (2019 - 2023)
Denali Therapeutics (DNLI) reported Tax Provisions of $30000.0 for Q4 2023, up 600.0% year-over-year from $4285.7 in Q4 2022, and up 600.0% on a QoQ basis from -$6000.0 in Q4 2022.
Denali Therapeutics (DNLI) has 5 years of Tax Provisions data on file, last reported at $30000.0 in Q4 2023.
- Quarterly Tax Provisions rose 600.0% year-over-year to $30000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $24000.0 (up 104.33% YoY) and the FY2025 annual result came in at $102000.0, up 50.0% from the prior year.
- Tax Provisions improved to $30000.0 in Q4 2023 per DNLI's latest filing, from -$6000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $823000.0 in Q4 2020 and bottomed at -$575000.0 in Q4 2021.
- The 5-year median for Tax Provisions is $10500.0 (2022), against an average of -$12700.0.
- The widest annual swing landed in 2021, when Tax Provisions slumped 169.87%; it then surged 600.0% in 2023.
- Tracing DNLI's Tax Provisions over 5 years: stood at -$113000.0 in 2019, then soared by 828.32% to $823000.0 in 2020, then tumbled by 169.87% to -$575000.0 in 2021, then soared by 98.96% to -$6000.0 in 2022, then surged by 600.0% to $30000.0 in 2023.
- Per Business Quant, the three latest DNLI Tax Provisions figures stand at $30000.0 (Q4 2023), -$6000.0 (Q4 2022), and $27000.0 (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 30,000.00 |
| Dec 31, 2022 | -6,000.00 |
| Jun 30, 2022 | 27,000.00 |
| Dec 31, 2021 | -575,000.00 |
| Dec 31, 2020 | 823,000.00 |
| Sep 30, 2020 | 56,000.00 |
| Jun 30, 2020 | 79,000.00 |
| Mar 31, 2020 | -135,000.00 |
| Sep 30, 2019 | -113,000.00 |
| Jun 30, 2019 | -313,000.00 |